Simplex Trading
MLNT

Simplex Trading’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Simplex Trading’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-539
Closed -$5K – 8850
2020
Q1 		$5K Sell
539
-246
-31% -$133 ﹤0.01% 6916
2019
Q4 		$41K Buy
785
+580
+283% +$1.41K ﹤0.01% 5388
2019
Q3 		$78K Sell
205
-864
-81% -$3.11K ﹤0.01% 4589
2019
Q2 		$710K Buy
1,069
+1,011
+1,743% +$3.85K ﹤0.01% 2247
2019
Q1 		$20K Buy
58
+52
+867% +$282 ﹤0.01% 5740
2018
Q4 		$2K Hold
6
– – ﹤0.01% 6672
2018
Q3 		$11K Sell
6
-2
-25% -$51 ﹤0.01% 6390
2018
Q2 		$24K Buy
+8
New +$288 ﹤0.01% 5734
2018
Q1 		– Sell
-49
Closed -$1K – 7286
2017
Q4 		$1K Buy
+49
New +$3.63K ﹤0.01% 5793

Simplex Trading's MLNT Position: Q2 2019 in Review

Simplex Trading sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2019, closing a stake of 892 shares — an estimated $3.4K sold.

Simplex Trading first reported a position in MLNT in Q2 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 53 funds tracked by Wall St. Rank hold MLNT as of Q2 2019.

  • Simplex Trading reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 892 Melinta Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $3.4K.
  • Simplex Trading first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Simplex Trading's Melinta Therapeutics, Inc. Common Stock position peaked at $3K in Q1 2019.
  • 53 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.